PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
EXPO vs. AME
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between EXPO and AME is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

EXPO vs. AME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Exponent, Inc. (EXPO) and AMETEK, Inc. (AME). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-10.99%
7.80%
EXPO
AME

Key characteristics

Sharpe Ratio

EXPO:

0.19

AME:

0.67

Sortino Ratio

EXPO:

0.54

AME:

1.01

Omega Ratio

EXPO:

1.08

AME:

1.16

Calmar Ratio

EXPO:

0.17

AME:

0.84

Martin Ratio

EXPO:

0.60

AME:

2.04

Ulcer Index

EXPO:

10.74%

AME:

7.13%

Daily Std Dev

EXPO:

33.98%

AME:

21.80%

Max Drawdown

EXPO:

-86.44%

AME:

-53.31%

Current Drawdown

EXPO:

-22.42%

AME:

-6.29%

Fundamentals

Market Cap

EXPO:

$4.71B

AME:

$41.83B

EPS

EXPO:

$2.05

AME:

$5.73

PE Ratio

EXPO:

45.04

AME:

31.54

PEG Ratio

EXPO:

3.14

AME:

2.78

Total Revenue (TTM)

EXPO:

$689.58M

AME:

$5.18B

Gross Profit (TTM)

EXPO:

$263.12M

AME:

$1.83B

EBITDA (TTM)

EXPO:

$150.93M

AME:

$1.57B

Returns By Period

In the year-to-date period, EXPO achieves a 5.44% return, which is significantly higher than AME's 2.46% return. Over the past 10 years, EXPO has outperformed AME with an annualized return of 17.73%, while AME has yielded a comparatively lower 15.04% annualized return.


EXPO

YTD

5.44%

1M

3.62%

6M

-10.99%

1Y

5.40%

5Y*

6.17%

10Y*

17.73%

AME

YTD

2.46%

1M

0.73%

6M

7.80%

1Y

13.92%

5Y*

13.70%

10Y*

15.04%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

EXPO vs. AME — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EXPO
The Risk-Adjusted Performance Rank of EXPO is 5151
Overall Rank
The Sharpe Ratio Rank of EXPO is 5353
Sharpe Ratio Rank
The Sortino Ratio Rank of EXPO is 4747
Sortino Ratio Rank
The Omega Ratio Rank of EXPO is 4848
Omega Ratio Rank
The Calmar Ratio Rank of EXPO is 5353
Calmar Ratio Rank
The Martin Ratio Rank of EXPO is 5353
Martin Ratio Rank

AME
The Risk-Adjusted Performance Rank of AME is 6767
Overall Rank
The Sharpe Ratio Rank of AME is 6969
Sharpe Ratio Rank
The Sortino Ratio Rank of AME is 5959
Sortino Ratio Rank
The Omega Ratio Rank of AME is 6363
Omega Ratio Rank
The Calmar Ratio Rank of AME is 7676
Calmar Ratio Rank
The Martin Ratio Rank of AME is 6666
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

EXPO vs. AME - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Exponent, Inc. (EXPO) and AMETEK, Inc. (AME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for EXPO, currently valued at 0.19, compared to the broader market-2.000.002.004.000.190.67
The chart of Sortino ratio for EXPO, currently valued at 0.54, compared to the broader market-4.00-2.000.002.004.006.000.541.01
The chart of Omega ratio for EXPO, currently valued at 1.08, compared to the broader market0.501.001.502.001.081.16
The chart of Calmar ratio for EXPO, currently valued at 0.17, compared to the broader market0.002.004.006.000.170.84
The chart of Martin ratio for EXPO, currently valued at 0.60, compared to the broader market0.0010.0020.0030.000.602.04
EXPO
AME

The current EXPO Sharpe Ratio is 0.19, which is lower than the AME Sharpe Ratio of 0.67. The chart below compares the historical Sharpe Ratios of EXPO and AME, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
0.19
0.67
EXPO
AME

Dividends

EXPO vs. AME - Dividend Comparison

EXPO's dividend yield for the trailing twelve months is around 1.19%, more than AME's 0.61% yield.


TTM20242023202220212020201920182017201620152014
EXPO
Exponent, Inc.
1.19%1.26%1.18%0.97%0.69%0.84%0.93%1.03%1.18%1.19%1.20%1.21%
AME
AMETEK, Inc.
0.61%0.62%0.61%0.63%0.54%0.60%0.56%0.83%0.50%0.74%0.67%0.63%

Drawdowns

EXPO vs. AME - Drawdown Comparison

The maximum EXPO drawdown since its inception was -86.44%, which is greater than AME's maximum drawdown of -53.31%. Use the drawdown chart below to compare losses from any high point for EXPO and AME. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-22.42%
-6.29%
EXPO
AME

Volatility

EXPO vs. AME - Volatility Comparison

Exponent, Inc. (EXPO) has a higher volatility of 6.22% compared to AMETEK, Inc. (AME) at 5.18%. This indicates that EXPO's price experiences larger fluctuations and is considered to be riskier than AME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%AugustSeptemberOctoberNovemberDecember2025
6.22%
5.18%
EXPO
AME

Financials

EXPO vs. AME - Financials Comparison

This section allows you to compare key financial metrics between Exponent, Inc. and AMETEK, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab